Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Peer Review reports

Original Submission
29 Aug 2020	Submitted	Original manuscript
26 Nov 2020	Reviewed	Reviewer Report
27 Dec 2020	Author responded	Author comments - Masahiro Yokoyama
Resubmission - Version 2
27 Dec 2020	Submitted	Manuscript version 2
6 Jan 2021	Reviewed	Reviewer Report
11 Feb 2021	Author responded	Author comments - Masahiro Yokoyama
Resubmission - Version 3
11 Feb 2021	Submitted	Manuscript version 3
Publishing
18 Mar 2021	Editorially accepted
6 Apr 2021	Article published	10.1186/s12885-021-08068-0

Back to article page